Hepatic insulin production for type 1 diabetes

Trends in Endocrinology and Metabolism

Volumn 12, Issue 10, 2001, Pages 441-446

  Dong, Hengjiang ^a   Woo, Savio L C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ANIMAL; BIOSYNTHESIS; GENE THERAPY; GENETICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KILLER CELL; LIVER; METABOLISM; PHYSIOLOGY; REVIEW; SECRETION; TRANSGENE;

ANIMALS; DIABETES MELLITUS, TYPE 1; GENE THERAPY; HUMANS; INSULIN; KILLER CELLS; LIVER; TRANSGENES;

EID: 0035656779     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(01)00491-X     Document Type: Review

References (63)

1. Bach, J.F. (1994) Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15, 516-542
2. DCCT (1997) Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46, 271-286
3. Shapiro, A.M. et al. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. New Engl. J. Med. 343, 230-238
4. Soria, B. et al. (2001) Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49, 157-162
5. Efrat, S. (1998) Cell-based therapy for insulin-dependent diabetes mellitus. Eur. J. Endocrinol. 138, 129-133
6. Levine, F. and Leibowitz, G. (1999) Towards gene therapy of diabetes mellitus. Mol. Med. Today 5, 165-171
7. Demeterco, C. and Levine, F (2001) Gene therapy for diabetes. Front. Biosci. 6, 175-191
8. Soria, B. et al. (2001) From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. Diabetologia 44, 407-415
9. Kay M.A. et al. (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat. Med. 7, 33-40
10. Lever, A.M. (2000) Lentiviral vectors: progress and potential. Curr. Opin. Mol. Ther. 2, 488-496
11. Buchschacher, G.L., Jr and Wong-Staal, F (2000) Development of lentiviral vectors for gene therapy for human diseases. Blood 95, 2499-2504
12. Parks, RJ. et al. (1996) A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. U. S. A. 93, 13565-13570
13. 1-antitrypsin with negligible toxicity Hum. Gene Ther. 9, 2709-2716
14. Morral, N. et al. (1999) Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. U. S. A. 96, 12816-12821
15. Snyder, R.O. (1999) Adeno-associated virus-mediated gene delivery. J. Gene Med. 1, 166-175
16. Monahan, P.E. and Samulski, RJ. (2000) Adeno-associated virus vectors for gene therapy: more pros than cons? Mol. Med. Today 6, 433-440
17. Nishikawa, M. and Huang, L. (2001) Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther. 12, 861-870
18. Burcelin, R. et al. (2000) Glucose sensing by the hepatoportal sensor is glut2-dependent. Diabetes 49, 1643-1648
19. Nordlie, R.C. et al. (1999) Regulation of glucose production by the liver. Annu. Rev. Nutr. 19, 379-406
20. Ennis, E.D. and Kreisberg, R.A. (1996) Diabetic ketoacidosis and the hyperglycemic hyperosmolar syndrome. In Diabetes Mellitus (LeRoith, D. et al., eds), pp. 121-132, Lippincott-Raven
21. Madsbad, S. et al. (1979) Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. Br. Med. J. 2, 1257-1259
22. Capaldo, B. et al. (1984) The response of blood intermediary metabolite levels to 24 hours treatment with a blood glucose-controlled insulin infusion system in type 1 diabetes. Diabetes Res. 1, 187-193
23. Rhodes, C.J. (1996) Processing of the insulin molecules. In Diabetes Mellitus (LeRoith, D. et al., eds), pp. 27-41, Lippincott-Raven
24. Muzzin, P. et al. (1997) Hepatic insulin gene expression as treatment for type I diabetes mellitus in rats. Mol. Endocrinol. 11, 833-837
25. Short, D.K. et al. (1998) Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice. Am. J. Physiol. 275, E748-E756
26. Lee, H.C. et al. (2000) Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature 408, 483-488
27. Lu, D. et al. (1996) Regulatable production of mature insulin from a hepatocyte cell line; insulin production is up-regulated by cAMP and glucocorticoids, and down-regulated by insulin. FEBS Lett. 399, 37-42
28. Lu, D. et al. (1998) Regulatable production of insulin from primary-cultured hepatocytes: insulin production is up-regulated by glucagon and cAMP and down-regulated by insulin. Gene Ther. 5, 888-895
29. Valera, A. et al. (1994) Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations. FASEB J. 8, 440-447
30. Gros, L. et al. (1999) Insulin production by engineered muscle cells. Hum. Gene Ther. 10, 1207-1217
31. Mitanchez, D. et al. (1997) Glucose-stimulated genes and prospects of gene therapy for type I diabetes. Endocr. Rev. 18, 520-540
32. Mitanchez, D. et al. (1998) Regulated expression of mature human insulin in the liver of transgenic mice. FEBS Lett. 421, 258-289
33. Wanke, I.E. and Wong, N.C. (1997) Specific problems facing gene therapy for insulin-dependent diabetes mellitus: glucose-regulated insulin secretion. Proc. West. Pharmacol. Soc. 40, 131-133
34. Chen, R. et al. (2000) Glucose-stimulated and self-limited insulin production from adenovirus transduced hepatoma cells. Gene Ther. 7, 1802-1809
35. Thule, P.M. et al. (2000) Glucose regulated production of human insulin in rat hepatocytes. Gene Ther. 7, 205-214
36. Thule, P.M. and Liu, J.M. (2000) Regulated hepatic insulin gene therapy of STZ-diabetic rats. Gene Ther. 7, 1744-1752
37. Chen, R. et al. (2001) Autoregulated hepatic insulin gene expression in type 1 diabetic rats. Mol. Ther. 3, 584-590
38. Barry, S.C. et al. (2001) Glucose-regulated insulin expression in diabetic rats. Hum. Gene Ther. 12, 131-139
39. Mithieux, G. (1997) New knowledge regarding glucose-6-phosphatase gene and protein and their roles in the regulation of glucose metabolism. Eur. J. Endocrinol, 137-145
40. Carpousis, A.J. et al. (1999) mRNA degradation. A tale of poly(A) and multiprotein machines. Trends Genet. 15, 24-28
41. Gay, E. and Babajko, S. (2000) AUUUA sequences compromise human insulin-like growth factor binding protein-1 mRNA stability. Biochem. Biophy. Res. Commun. 267, 509-515
42. Shyu, A-B. et al. (1991) Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes Dev. 5, 221-231
43. Taniguchi, K. et al. (1996) Control of proinsulin production by sense-anti-sense regulation in response to glucocorticoids. Cell Transplant. 5 (Suppl. 1), S55-S57
44. Wicksteed, B. et al. (2001) Cooperativity between the preproinsulin mRNA untranslated regions is necessary for glucose-stimulated translation. J. Biol. Chem. 276, 22553-22558
45. Vivinus, S. et al. (2001) An element within the 5′ untranslated region of human hsp70 mRNA which acts as a general enhancer of mRNA translation. Eur. J. Biochem. 268, 1908-1917
46. Rivera, V.M. et al. (2000) Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum. Science 287, 826-830
47. Dong, H. et al. (2001) Hepatic insulin expression improves glycemic control in type 1 diabetic rats. Diabetes Res. Clin. Pract. 52, 153-163
48. Sugiyama, A. et al. (1997) Defective adenoassociated viral-mediated transfection of insulin gene by direct injection into liver parenchyma decreases blood glucose of diabetic mice. Horm. Metab. Res. 29, 599-603
49. Falqui, L. et al. (1999) Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin. Hum. Gene Ther. 10, 1753-1762
50. Lepore, M. et al. (2000) Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analogs glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49, 2142-2148
51. Guthrie, R. (2001) Is there a need for a better basal insulin? Clin. Diab. 19, 66-70
52. Bolli, G.B. et al. (1999) Insulin analogs and their potential in the management of diabetes mellitus. Diabetologia 42, 1151-1167
53. Dagogo-Jack, S. et al. (2000) Physiological responses during hypoglycemia induced by regular human insulin or a novel human insulin analogue, insulin glargine. Diab. Obesity Metabol. 2, 373-383
54. Raskin, P. et al. (2000) A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care 23, 1666-1671
55. Rosenstock, J. et al. (2000) Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. Diabetes Care 23, 1137-1142
56. Slieker, L.J. etal. (1997) Modifications in the B10 and B26-30 regions of hte B chain of human insulin alter affinity for the human IGE-1 receptor more than for the insulin receptor. Diabetologia 40, S54-61
57. Kurtzhals, P. et al. (2000) Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49, 999-1005
58. Thompson, J.S. and Duckworth, W.C. (2001) Insulin pumps and glucose regulation. World J. Surg. 25, 523-526
59. Yeung, C.M. et al. (1999) Glucose-dependent insulinotropic polypeptide gene expression in the stomach: revealed by a transgenic mouse study, in situ hybridization and immunohistochemical staining. Mol. Cell. Endocrinol. 154, 161-170
60. Cheung, A.T. et al. (2000) Glucose-dependent insulin release from genetically engineered K cells. Science 290, 1959-1962
61. Corbett, J .A. (2001) K cells: a novel target for insulin gene therapy for prevention of diabetes. Trends Endocrinol. Metab. 12, 140-142
62. Damholt, A.B. et al. (1999) Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine. Cell Tissue Res. 298, 287-293
63. Berlanga-Acosta, J. et al. (2001) Gastrointestinal cell proliferation and crypt fission are separate but complementary means of increasing tissue mass following infusion of epidermal growth factor in rats. Gut 48, 803-807